Yan Shengmin
Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Biomolecules. 2022 May 6;12(5):672. doi: 10.3390/biom12050672.
The transcription factor EB (TFEB) is a master regulator of lysosomal function and autophagy. Mechanistic target of rapamycin (mTOR)-mediated phosphorylation on TFEB is known to regulate TFEB subcellular localization and activity at the lysosomal surface. Recent studies have shown that TFEB also plays a critical role in physiological processes such as lipid metabolism, and dysfunction of TFEB has been observed in the pathogenesis of several diseases. Owing to its ability to improve disease status in murine models, TFEB has attracted attention as a therapeutic target for diseases. In this review, we will present the regulation of TFEB and its role in the pathogenesis of liver diseases, particularly non-alcoholic fatty liver disease (NAFLD).
转录因子EB(TFEB)是溶酶体功能和自噬的主要调节因子。已知雷帕霉素的机制性靶标(mTOR)介导的TFEB磷酸化可调节TFEB在溶酶体表面的亚细胞定位和活性。最近的研究表明,TFEB在脂质代谢等生理过程中也起着关键作用,并且在几种疾病的发病机制中已观察到TFEB功能障碍。由于其能够改善小鼠模型中的疾病状态,TFEB作为疾病的治疗靶点已引起关注。在本综述中,我们将介绍TFEB的调节及其在肝脏疾病,特别是非酒精性脂肪性肝病(NAFLD)发病机制中的作用。